Factors Predictive of Response and Survival in Patients with Metastatic Colorectal Cancer in Taiwan

Japanese Journal of Clinical Oncology

Volumn 27, Issue 3, 1997, Pages 174-179

  Wang, Wei Shu ^a   Fan, Frank S ^b   Hsieh, Ruey Kuen ^b   Chiou, Tzeon Jye ^b   Lin, Jen Kou ^b   Lin, Tzu Chen ^b   Yen, Chueh Chuan ^b   Liu, Jin Hwang ^b   Hsu, Hung ^b   Chen, Po Min ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

5 fluororacil; Leucovorin; Metastatic colorectal cancer; Prognostic factor

Indexed keywords

ANTIDOTE; ANTINEOPLASTIC ANTIMETABOLITE; FLUOROURACIL; FOLINIC ACID; IMMUNOLOGICAL ADJUVANT; LEVAMISOLE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLORECTAL TUMOR; DRUG ADMINISTRATION; FEMALE; HUMAN; INJECTION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; REMISSION; SURVIVAL;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; ANTIDOTES; ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS; LEUCOVORIN; LEVAMISOLE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; REMISSION INDUCTION; SURVIVAL ANALYSIS;

EID: 0031159471     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/27.3.174     Document Type: Article

References (22)

1. Edler L, Heim ME, Quintero C, Brummer T, Queisser W. Prognostic factors of advanced colorectal cancer patients. Eur J Cancer Clin Oncol 1986;22:1231-7.
2. Erlichman C, Fine S, Wong A, Elhakim T. A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 1988;6:469-75.
3. Graf W, Glimelius B, Pahlman L, Bergstrom R Determinants of prognosis in advanced colorectal cancer. Eur J Cancer 1991;27:1119-23.
4. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastasis. Lancet 1994;343:1405-10
5. Lavin P, Mittelman A, Douglass H Jr, Engstrom P, Klaassen D. Survival and response to chemotherapy for advanced colorectal adenocarcinoma. Cancer 1980;46:1536-43.
6. Kemeny N, Braun DW Jr. Prognostic factors in advanced colorectal carcinoma. Importance of lactic dehydrogenase level, performance status and white blood cell count. Am J Med 1983;74:786-94.
7. Moertal CG, O'Fallon JR, Go VLW, O'Connell MJ, Thynne GS. The preoperative carcinoembryonic antigen test in the diagnosis, staging and prognosis of colorectal cancer. Cancer 1986;58.603-10.
8. Schoenfeld D. Chi-squared tests for the proportional hazards regression model. Biometrika 1980;67:145-53.
9. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
10. Peto R, Pike MD. Conservatism of the approximation in the log-rank test for survival data or tumor incidence data. Biometrics 1973;29:579-84.
11. Cox DR. Regression models and life tables. JR Stat Soc Br 1972;34:187-220.
12. Lokich JJ, Moore C. Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. Ann Intern Med 1984;101:798-800.
13. Heidelberger C, Chaudhari NK, Danneberg P. Fluorinated pyrimidine. A new class of tumor-inhibitory compounds. Nature 1957;179:663-6.
14. Petrelli N, Douglass HO Jr, Herrera L. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. J Clin Oncol 1989;7:1419-26.
15. Mutch RS, Hutson DR. Levamisole in the adjuvant treatment of colon cancer. Clin Pharm 1991;10:95-109
16. Seifert P, Baker LH, Reed ML Comparison of continuously infused 5-fluorouracil with bolus injection in the treatment of patients with colorectal adenocarcinoma. Cancer 1975;36.123-8.
17. Lokich J, Fine N, Pern J Protracted ambulatory venous infusion of 5-fluorouracil. Am J Clin Oncol 1983;6.103-7.
18. Shah A, MacDonald W, Goldie J, Gudauskas G, Brisebois B. 5-FU infusion in advanced colorectal cancer: a comparison of three dose schedules. Cancer Treat Rep 1985:69:739-42.
19. Lokich JJ, Ahlgren JD, Gullo JJ, Philips JA, Fryer JG. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma. J Clin Oncol 1989;7:425-32.
20. Finan RJ, Marshall RJ, Cooper EH, Giles GR. Factors affecting survival in patients with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis. Br J Surg 1985;72:373-7.
21. Goslin R, Steele G, Zamcheck N, Mayer R, MacIntyre J Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum 1982;25:749-54.
22. Slentz K, Senagore A, Hibbert J, Mazier WP, Talbott TM. Can preoperative and postoperative CEA predict survival after colon cancer resection. Am J Surg 1994;60:528-32.